Brette L. Trost
Lawyers
Filters
MediaAlpha $144.2 million secondary offering
The Class A common stock is listed on the New York Stock Exchange
AC Immune exclusive option and license agreement with Takeda Pharmaceuticals
We advised AC Immune on the transaction
Biodesix $55 million follow-on offering
The common stock is listed on the Nasdaq Global Market
MediaAlpha $59.6 million secondary offering
The stock is listed on the New York Stock Exchange
Prime Medicine $161 million stock and pre-funded warrants offering
The common stock is listed on the Nasdaq Global Market
Estée Lauder $650 million senior notes offering
The investment-grade notes are due 2034
Truist sale of Sterling Capital Management to Guardian Capital
We are advising Truist on the transaction
TKO Group Holdings $666 million secondary offering
The stock is listed on the New York Stock Exchange
GSK exclusive license agreement for HS-20089 with Hansoh Pharma
We advised GSK on the transaction
Ferrara Candy acquisition of Jelly Belly Candy
We are advising Ferrara on the acquisition